E. O'BRIAN SMITH to Biomarkers
This is a "connection" page, showing publications E. O'BRIAN SMITH has written about Biomarkers.
Connection Strength
0.155
-
Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2014 Dec; 15(8):543-9.
Score: 0.061
-
Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia. J Perinatol. 2007 May; 27(5):303-6.
Score: 0.037
-
Serum KL-6 level and the development of bronchiolitis obliterans syndrome in lung transplant recipients. Pediatr Transplant. 2010 Nov; 14(7):903-8.
Score: 0.012
-
Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. Thorax. 2009 Aug; 64(8):677-81.
Score: 0.011
-
Safety and efficacy of nesiritide in pediatric heart failure. J Card Fail. 2007 Sep; 13(7):541-8.
Score: 0.010
-
A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Pediatr Cardiol. 2006 Jul-Aug; 27(4):402-7.
Score: 0.009
-
Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem. 2005 Jul; 51(7):1102-9.
Score: 0.008
-
Spinal fluid 5-methyltetrahydrofolate levels are normal in Rett syndrome. Neurology. 2005 Jun 28; 64(12):2151-2.
Score: 0.008